Pooled association genome scanning: validation and use to identify addiction vulnerability loci in two samples
- PMID: 16091475
- PMCID: PMC1183486
- DOI: 10.1073/pnas.0500329102
Pooled association genome scanning: validation and use to identify addiction vulnerability loci in two samples
Abstract
Association genome scanning is of increasing interest for identifying the chromosomal regions that contain gene variants that contribute to vulnerability to complex disorders, including addictions. To improve the power and feasibility of this approach, we have validated "10k" microarray-based allelic frequency assessments in pooled DNA samples and have used this approach to seek allelic frequency differences between heavy poly-substance abusers and well characterized control individuals. Thirty-eight loci contain SNPs that display robust allele frequency differences between abusers and controls in both European- and African-American samples. These loci identify an alcohol/acetaldehyde dehydrogenase gene cluster and genes implicated in cellular signaling, gene regulation, development, "cell adhesion," and Mendelian disorders. The results converge with previous linkage and association results for addictions. Pooled association genome scanning provides a useful tool for elucidating molecular genetic underpinnings of complex disorders and identifies both previously understood and previously unanticipated mechanisms for addiction vulnerability.
Figures

Similar articles
-
Pooled association genome scanning for alcohol dependence using 104,268 SNPs: validation and use to identify alcoholism vulnerability loci in unrelated individuals from the collaborative study on the genetics of alcoholism.Am J Med Genet B Neuropsychiatr Genet. 2006 Dec 5;141B(8):844-53. doi: 10.1002/ajmg.b.30346. Am J Med Genet B Neuropsychiatr Genet. 2006. PMID: 16894614 Free PMC article.
-
Addiction molecular genetics: 639,401 SNP whole genome association identifies many "cell adhesion" genes.Am J Med Genet B Neuropsychiatr Genet. 2006 Dec 5;141B(8):918-25. doi: 10.1002/ajmg.b.30436. Am J Med Genet B Neuropsychiatr Genet. 2006. PMID: 17099884
-
Genomic regions identified by overlapping clusters of nominally-positive SNPs from genome-wide studies of alcohol and illegal substance dependence.PLoS One. 2011;6(7):e19210. doi: 10.1371/journal.pone.0019210. Epub 2011 Jul 27. PLoS One. 2011. PMID: 21818250 Free PMC article.
-
Molecular genetics of substance abuse vulnerability: remarkable recent convergence of genome scan results.Ann N Y Acad Sci. 2004 Oct;1025:1-13. doi: 10.1196/annals.1316.001. Ann N Y Acad Sci. 2004. PMID: 15542694 Review.
-
Substance abuse vulnerability loci: converging genome scanning data.Trends Genet. 2002 Aug;18(8):420-5. doi: 10.1016/s0168-9525(02)02719-1. Trends Genet. 2002. PMID: 12142011 Review.
Cited by
-
Identification of variants from gene expression data of opioid-addicted patients.J Appl Genet. 2025 Jul 8. doi: 10.1007/s13353-025-00989-x. Online ahead of print. J Appl Genet. 2025. PMID: 40627269
-
Pooled association genome scanning for alcohol dependence using 104,268 SNPs: validation and use to identify alcoholism vulnerability loci in unrelated individuals from the collaborative study on the genetics of alcoholism.Am J Med Genet B Neuropsychiatr Genet. 2006 Dec 5;141B(8):844-53. doi: 10.1002/ajmg.b.30346. Am J Med Genet B Neuropsychiatr Genet. 2006. PMID: 16894614 Free PMC article.
-
"Higher order" addiction molecular genetics: convergent data from genome-wide association in humans and mice.Biochem Pharmacol. 2008 Jan 1;75(1):98-111. doi: 10.1016/j.bcp.2007.06.042. Epub 2007 Jul 25. Biochem Pharmacol. 2008. PMID: 17764662 Free PMC article. Review.
-
Structure-activity studies of PTPRD phosphatase inhibitors identify a 7-cyclopentymethoxy illudalic acid analog candidate for development.Biochem Pharmacol. 2022 Jan;195:114868. doi: 10.1016/j.bcp.2021.114868. Epub 2021 Dec 2. Biochem Pharmacol. 2022. PMID: 34863978 Free PMC article.
-
Genotype patterns that contribute to increased risk for or protection from developing heroin addiction.Mol Psychiatry. 2008 Apr;13(4):417-28. doi: 10.1038/sj.mp.4002147. Epub 2008 Jan 15. Mol Psychiatry. 2008. PMID: 18195715 Free PMC article.
References
-
- Uhl, G. R., Elmer, G. I., Labuda, M. C. & Pickens, R. W. (1995) in Psychopharmacology: The Fourth Generation of Progress, eds. Gloom, F. E. & Kupfer, D. J. (Raven, New York), pp. 1793-2783.
-
- Uhl, G. R. (1999) Neuropsychopharmacology 20, 3-9. - PubMed
-
- Cadoret, R. J., Troughton, E., O'Gorman, T. W. & Heywood, E. (1986) Arch. Gen. Psychiatry 43, 1131-1136. - PubMed
-
- Cadoret, R. J., Yates, W. R., Troughton, E., Woodworth, G. & Stewart, M. A. (1995) Arch. Gen. Psychiatry 52, 42-52. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical